65 results
Page 2 of 4
8-K
EX-99.1
stn4ey2uc2pdcpes0nw
31 May 22
Entry into a Material Definitive Agreement
8:52am
8-K
EX-99.1
37q506h 1zq
22 Jul 21
JanOne Selects CPC Clinical Research as Trial Manager for Phase 2b Study of JAN101 for Peripheral Artery Disease Patients
9:46am
8-K
EX-99.1
3njgd6m ddco
23 Jun 21
Company Fully Prepared to Commence Phase 2b Trials of JAN101 for Peripheral Artery Disease (PAD) as Soon as New Protocol is Approved by the FDA
10:14am
8-K
EX-99.1
yvicwo4nrax6
22 Jun 21
JanOne Selects Regulatory Partner for Phase 2b Trial as Investigational Plan is Prepared for FDA Filing
9:46am
8-K
EX-99.1
ncxwy76kz0zn
15 Jun 21
JanOne Appoints Internationally Renowned Expert on Addiction Nicholas Goeders, Ph.D. to Scientific Advisory Board
10:16am
8-K
EX-99.1
pel1gaqa 71
8 Jun 21
Other Events
9:45am
8-K
EX-99.1
8j3l82ys9mit
25 Feb 21
JanOne Announces Definitive Agreement to Sell its Legacy Recycling Business for $25 Million
4:05pm
8-K
EX-99.1
j8c0ogidyga74am5pss
2 Feb 21
JanOne Announces Closing of $6.0 Million Common Stock Offering
5:27pm
424B5
tdoz 4sck
2 Feb 21
Prospectus supplement for primary offering
1:30pm
8-K
EX-99.1
48oduscpve4aa756li
29 Jan 21
JanOne Prices $6.0 Million Common Stock Offering
9:08am